期刊文献+

ERG11基因突变与白念珠菌对氟康唑耐药性的初步研究 被引量:6

Research on ERG11 gene mutations in Candida albicans resistance to fluconazole
下载PDF
导出
摘要 目的探讨白念珠菌氟康唑作用的靶酶编码基因(ERG11)突变与氟康唑耐药性的关系。方法采用聚合酶链反应(PCR)扩增临床分离的23株白念珠菌ERG11基因,包括2株耐氟康唑株、9株氟康唑剂量依赖敏感株和12株氟康唑敏感株,并进行双向测序。应用B last软件,将测序结果与网上已发表序列(GenBankAY856352)进行比对,以确定是否发生基因突变。结果23株白念珠菌的ERG11基因序列共检出16个同义突变位点和18个错义突变位点。错义突变中Y205E、I437V、A255V、E260V、K487N、G472R、N435V、D502E、K143Q为新发现的突变位点。结论Y205E、I437V、A255V位点突变发现于敏感株,可能与白念珠菌耐药无关;K487N、G472R、N435V、D502E、E260V发现于剂量依赖敏感株,K143Q发现于耐药株,可能与耐药的形成有关。 Objective To study the relationship between fluconazole-resistance of Candida albicans and the mutation of ERG11 gene encoding fluconazole-targeted enzyme.Methods The genes of 23 strains Candida albicans isolated from patients,including 2 strains of fluconazole-resistance,9 strains of fluconazole-susceptible dose dependent and 12 strains of fluconazole-susceptible,were amplified by polymerase chain reaction(PCR) and bilaterally sequenced.The sequencing results were analyzed by Blast and compared with published sequence(GenBank AY856352) to find out the locations of mutation.Results 16 silent mutations and 18 missense mutations were identified in 23 Candida albicans isolates.Among the missense mutations,Y205E,I437V,A255V,E260V,K487N,G472R,N435V,D502E and K143Q had not been found yet in the previous studies.Conclusions Resistant mechanism of Candida albicans to fluconazole may be correlated with the mutations of K487N,G472R,N435V,D502E,E260V and K143Q in ERG11 gene which existed in fluconazole-susceptible dose dependent and fluconazole-resistance isolates,but not with mutations of Y205E,I437V and A255V which existed in fluconazole-susceptible isolates.
出处 《检验医学》 CAS 北大核心 2009年第12期856-860,共5页 Laboratory Medicine
基金 上海市卫生局科技发展基金资助项目(054118) 卢湾区卫生系统学科带头人培养计划资助项目(200501)
关键词 白念珠菌 ERG11基因 耐药性 氟康唑 基因突变 Candida albicans ERG11 gene Resistance Fluconazole Gene mutation
  • 相关文献

参考文献12

  • 1徐英春,李若瑜,倪语星,张秀珍,俞云松,胡必杰.如何正确理解抗真菌药物体外敏感试验结果对临床用药的指导价值[J].中华检验医学杂志,2008,31(2):128-132. 被引量:20
  • 2徐永豪,李春阳.耐唑类药白念珠菌ERG11基因点突变[J].中国真菌学杂志,2006,1(6):370-373. 被引量:8
  • 3National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts[ S]. M27-A2 ,NCCLS ,2002.
  • 4Perea S, Patterson TF. Antifungal resistance in pathogenic fungi[ J ]. Clin Infect Dis, 2002, 35 (9) : 1073-1080.
  • 5Perea S, Lopez-Ribot JL, Kirkpatrick WR, et al. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficieney virus-infected patients [ J ]. Antimicrob Agents Chemother, 2001,45 (10) : 2676-2684.
  • 6Marichal P,Koymans L,Willemsens S, et al. Contribution of mutations in the cytochrome P450 14alpha- demethylase ( Ergl 1 p, Cyp51 p) to azole resistance in Candida albicans [ J ]. Microbiology, 1999, 145 (Pt10) :2701-2713.
  • 7Sanglard D, Ischer F, Koymans L, et al. Amino acid substitutions in the cytochrorne P-450 lanosterol 14 alpha-demethylase ( CYP51A1 ) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents [ J ]. Antimicrob Agents Chemother, 1998,42 (2) :241-253.
  • 8周辉,龙铁军.Erg11基因突变与白念珠菌对唑类药物耐药性的初步研究[J].中国感染与化疗杂志,2007,7(2):108-110. 被引量:7
  • 9Loffler J, Kelly SL, Hebart H, et al. Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains [ J ]. FEMS Microbiol Lett, 1997, 151 (2) : 263 -268.
  • 10Goldman Girl, Da Silva Ferreira ME, Dos Reis Marques E, et al. Evaluation of fluconazole resistance mechanisms in Candida albicans clinical isolates from HIV-infected patients in Brazil[ J]. Diagn Microbiol Infect Dis, 2004, 50( 1 ) : 25-32.

二级参考文献22

  • 1刘伟,李若瑜.抗真菌药物敏感性试验在真菌感染防治中的作用[J].中华检验医学杂志,2005,28(4):349-351. 被引量:30
  • 2王应斌,王宏,郭辉玉,赵永忠,罗深秋.白假丝酵母ERG11基因突变分析[J].第一军医大学学报,2005,25(11):1390-1393. 被引量:9
  • 3王澎,陈翠珠,徐英春,谢秀丽,王瑶,王辉,陈民钧.4种抗真菌药对82株丝状真菌体外抗菌活性的临床研究[J].中国实用内科杂志,2006,26(4):547-549. 被引量:5
  • 4M27-A2 Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. 2nd ed. 2002.22(15):1-30.
  • 5M38-A, Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, Approved Standard. 2002.22(16):1-30.
  • 6Lass-florl C, Kofler G, Kropshofer G, et al. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicro Chemoth, 1998,42:497-502.
  • 7Pfaller MA, Boyken L, Hollis RJ,et al. In vitro susceptibilities of clinical isolates of Candida species, cryptococcus neoformans, and Aspergillus species to itraconazole:global survey of 9359 isolates tested by Clinical and Laboratory Standards Institute Broth Microdilution Methods. J Clin Microb ,2005,43:3807-3810.
  • 8Willems L, van der C, eest R, de Beule K. Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics. J Clin Phar Ther, 2001,26:159-169.
  • 9Fothergill AW, Rinaldi MG,Sutton DA. Antifungal susceptibility testing. Infect Dis Clin North Am,2006,20:699-700.
  • 10Pfaller MA, Diekema D J, Sheehan DJ. Interpretive breakpoints for fluconazole and Candida revisited: a blueprint of the future for antifungal susceptibility testing. Clin Microbiol Rev,2006,19:435-447.

共引文献31

同被引文献74

  • 1肖敦振,赵丁源,高俊,姚念.农村地区RVVC病人阴道内所分离的假丝酵母菌分型和药敏分析[J].中国妇幼保健,2005,20(2):158-160. 被引量:3
  • 2江惟苏,谭升顺,江国英,陈庆秀.特比萘芬与氟康唑或伊曲康唑联合对氟康唑诱导耐药稳定白念珠菌的影响[J].中华微生物学和免疫学杂志,2006,26(4):360-364. 被引量:5
  • 3徐永豪,李春阳.耐唑类药白念珠菌ERG11基因点突变[J].中国真菌学杂志,2006,1(6):370-373. 被引量:8
  • 4周辉,龙铁军.Erg11基因突变与白念珠菌对唑类药物耐药性的初步研究[J].中国感染与化疗杂志,2007,7(2):108-110. 被引量:7
  • 5Podust LM, Poulos TL,Waterman MR. Crystal structure ofcytochrome P450 14alpha-sterol demethylase(CYP51) fromMycobacteriam tuberculosis in complex with azole inhibitors.Proc Natl Acad Sci USA, 2001,98:3068-3073.
  • 6Marichal P, Koymans L, Willemsens S, et al. Contributionof mutations in the cytochrome P450 14alpha-demethylase(Ergllp, Cyp51p) to azole resistance in Candida albicans.Microbiology, 1999,145 = 2701-2713.
  • 7Sanglard D, Ischer F,Koymans L, et al. Amino acidsubstitutions in the cytochrome P-450 lanosterol 14alpha-demethylase( CYP51A1) from azole-resistant Candidaalbicans clinical isolates contribute to resistance to azoleantifungal agents. Antimicrob Agents Chemother, 1998,42:241-253.
  • 8White TC. The presence of an R467K amino acidsubstitution and loss of allelic variation correlate with anazole-resistant ianosterol 14alpha demethylase in Candidaalbicans. Antimicrob Agents Chemother, 1997,41:1488-1494.
  • 9Franz R, Kelly SL,Lamb DC, et al. Multiple molecularmechanisms contribute to a stepwise development offluconazole resistance in clinical Candida albicans strains.Antimicrob Agents Chemother, 1998, 42:3065-3072.
  • 10Aoyama Y. Kudo M,Asai K,et al. Emergence offluconazole-resistant sterol 14-demethylase P450(CYP51) inCandida albicans is a model demonstrating the diversificationmechanism of P450. Arch Biochem Biophys, 2000,379:170-171.

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部